Hemostasis in malignancy

No abstract is available for this paper.

• Publication year

  1990

• Venue

  American journal of hematology/oncology

• Publication date

  1990-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ajh.2830350111PMID 2202206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations of Hemostasis Associated With Malignancy: Etiology, Pathophysiology, Diagnosis and Management

  2008cited by this paper
• Mechanisms of Hemorrhage in Leukemias

  2008cited by this paper
• Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital.

  1989cited by this paper
• The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u‐PA rather than defibrination

  1989cited by this paper
• Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231.

  1989cited by this paper
• A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.

  1989cited by this paper
• Different expression of procoagulant activity in macrophages associated with experimental and human tumors.

  1988cited by this paper
• Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis.

  1988cited by this paper
• Platelet contribution to cancer cell growth and migration: the role of platelet growth factors.

  1988cited by this paper
• Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients.

  1988cited by this paper
• Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation.

  1988cited by this paper
• The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

  1988cited by this paper
• Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo.

  1988cited by this paper
• Chemotherapy for breast cancer decreases plasma protein C and protein S.

  1988cited by this paper
• Treatment of Disseminated Intravascular Coagulation

  1988cited by this paper
• A new procoagulant in acute leukemia.

  1988cited by this paper
• Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?

  1987cited by this paper
• The regulation of natural anticoagulant pathways

  1987cited by this paper
• Investigation of the antimetastatic effects of agents that inhibit cell adhesion or protein glycosylation.

  1987cited by this paper
• The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation.

  1987cited by this paper
• Depressed fibrinolysis in patients with acute leukaemia

  1987cited by this paper
• Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications.

  1987cited by this paper
• Absence of thrombosis in subjects with heterozygous protein C deficiency.

  1987cited by this paper
• Cancer and venous thromboembolism.

  1987cited by this paper
• Occult malignant neoplasm in patients with deep venous thrombosis.

  1987cited by this paper
• Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

  1986cited by this paper
• Acute promyelocytic leukemia. M.D. Anderson Hospital experience.

  1986cited by this paper
• Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors.

  1986cited by this paper
• Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.

  1986cited by this paper
• Mechanisms of Inhibition of Cancer Dissemination by Warfarin

  1986cited by this paper
• Basis for selection of anticoagulant drugs for therapeutic trials in human malignancy.

  1986cited by this paper
• The regulation of hemostasis: the protein C system.

  1986cited by this paper
• Interferon treatment of human neoplasia.

  1986cited by this paper
• Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

  1986cited by this paper
• Deep venous thrombosis during therapy for Hodgkin's disease.

  1985cited by this paper
• Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

  1985cited by this paper
• Novel factor X deficiency. Normal partial thromboplastin time and associated spindle cell thymoma.

  1985cited by this paper
• The hypercoagulable states.

  1985cited by this paper
• Trousseau's syndrome. Devastating coagulopathy in the absence of heparin.

  1985cited by this paper
• High Fibrinopeptide A (FPA) Levels in Acute Non-Lymphocytic Leukemia Are Reduced by Heparin Administration

  1984cited by this paper
• Tumor Cysteine Proteinases, Platelet Aggregation and Metastasis

  1984cited by this paper
• Fibrin Formation: Implications for Tumor Growth and Metastasis

  1984cited by this paper
• Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia

  1984cited by this paper
• Plasminogen Activators In Human Malignant Melanoma

  1984cited by this paper
• Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies.

  1984cited by this paper
• Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final Report of VA cooperative study # 75

  1984cited by this paper
• Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia.

  1984cited by this paper
• Thrombin generation in acute promyelocytic leukemia.

  1984cited by this paper
• Hyperviscosity caused by hyaluronic acid in serum in a case of Wilms' tumor.

  1984cited by this paper
• Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas.

  1984cited by this paper
• Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

  1983cited by this paper
• Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.

  1983cited by this paper
• Thromboembolism in cancer patients.

  1983cited by this paper
• Abnormalities of blood coagulation in patients with cancer: Fibrinopeptide a generation and tumor growth

  1983cited by this paper
• Acquired factor XIII deficiency with chronic myelomonocytic leukemia.

  1983cited by this paper
• Interaction of Human Tumor Cells with Human Platelets and the Coagulation System

  1983cited by this paper
• The secretion of plasminogen activators by human myeloid leukemic cells in vitro.

  1983cited by this paper
• Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

  1983cited by this paper
• Expression of procoagulant activity in a human monocyte-like cell line.

  1983cited by this paper
• Cryptic and active plasminogen activators secreted by line 10 tumor cells in culture.

  1983cited by this paper
• Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients.

  1982cited by this paper
• Comparison Of 125-I Fibrinogen Kinetics And Fibrinopeptide A In Patients With Disseminated Neoplasias

  1982cited by this paper
• Occult cancer in patients with acute pulmonary embolism.

  1982cited by this paper
• Tissue Factor-Like Activity Of The Human Monocytic Tumor Cell Line U937

  1982cited by this paper
• Immune complex-induced human monocyte procoagulant activity. II. Cellular kinetics and metabolic requirements.

  1982cited by this paper
• Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells.

  1982cited by this paper
• Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

  1982cited by this paper
• Nonbacterial Thrombotic Endocarditis: A Neurologic Perspective of Clinicopathologic Correlations of 99 Patients

  1982cited by this paper
• A factor X-activating cysteine protease from malignant tissue.

  1981cited by this paper
• Tumor shedding and coagulation.

  1981cited by this paper
• Idiosyncratic platelet responses to human tumour cells

  1981cited by this paper
• ROLE OF PLATELETS IN TUMOR CELL METASTASES

  1981cited by this paper
• Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75.

  1981cited by this paper
• Venous thrombosis during multimodal treatment of primary breast carcinoma.

  1981cited by this paper
• Role of platelets in tumor cell metastases.

  1981cited by this paper
• Antithrombin III Profiles in Malignancy, Relationship to Primary Tumors and Metastatic Sites

  1981cited by this paper
• Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway

  1981cited by this paper
• Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation.

  1981cited by this paper
• Fibrinopeptide A (FPA) Level and Fibrinogen Kinetics in Patients with Malignant Disease

  1981cited by this paper
• Shedding from the cell surface of normal and cancer cells.

  1980cited by this paper
• Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.

  1980cited by this paper
• Factor X-activating activity from Lewis lung carcinoma.

  1980cited by this paper
• Mucin‐producing adenocarcinomas and nonbacterial thrombotic endocarditis. Pathogenetic role of tumor mucin

  1980cited by this paper
• Molecular species of plasminogen activators secreted by normal and neoplastic human cells.

  1980cited by this paper
• Measurements of antithrombin III in solid tumor patients with and without hepatic metastases.

  1980cited by this paper
• Reduced procoagulant activity of Lewis lung carcinoma cells from mice treated with warfarin.

  1980cited by this paper
• MALIGNANCY AND HAEMOSTASIS

  1980cited by this paper
• Characterization of the platelet-aggregating activity of tumor cells.

  1980cited by this paper
• Shedding from normal and cancer-cell surfaces.

  1980cited by this paper
• Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.

  1980cited by this paper
• Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line.

  1980cited by this paper
• Alterations of host defenses paralleling cholesterol-induced atherogenesis. I. Interactions of prolonged experimental hypercholesterolemia and infections.

  1979cited by this paper
• Immunological characterization of multiple weight forms of human cell plasminogen activators.

  1979cited by this paper
• Comparison of procoagulant activities in extracts of normal and malignant human tissue.

  1979cited by this paper
• Anticoagulants in the treatment of small cell carcinoma of the bronchus.

  1979cited by this paper
• Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis.

  1979cited by this paper
• alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy.

  1979cited by this paper
• Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies.

  1979cited by this paper
• Thrombotic complications in patients with advanced prostatic cancer treated with chemotherapy.

  1979cited by this paper
• Heparinized chemotherapy in the treatment of disseminated lung cancer.

  1979cited by this paper

• Influencing Factor Analysis and Predictive Model Development for Platelet Transfusion Refractoriness in Pediatric Oncology Patients

  2025cites this paper
• Identification of novel ceRNA networks associated with system hemostasis and their prognostic implication in lung squamous cell carcinoma.

  2025cites this paper
• Contribution of Cancer-Specific Protein Coronas to the Pro-Tumor Effects of Nanoplastics through Enhanced Cellular Interactions.

  2024cites this paper
• Efficacy of a novel self-assembling peptide gel for hemostasis in refractory neoplastic bleeding

  2023cites this paper
• Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study

  2020cites this paper
• Evaluating platelet activation related to the degradation products of biomaterials using molecular markers.

  2020cites this paper
• Evaluating platelet activation related to the degradation of biomaterials using molecular markers.

  2019cites this paper
• Thrombosis Risk in Acquired Risk Situations : The Leiden Thrombophilia Study

  2018cites this paper
• Abdominal surgery in patients with essential thrombocythemia

  2017cites this paper
• Infarto cerebral como manifestación inicial del síndrome de Trousseau en una mujer joven

  2015cites this paper
• Solid Malignensili Hastalarda Hiperkoagülabilite ve Hiperkoagülabilitenin Tromboelastografi ile Değerlendirilmesi

  2015cites this paper
• The Role of Fibrinogen as a Predictor in Preoperative Chemoradiation for Rectal Cancer

  2014cites this paper
• Kelainan Hemostasis pada Leukemia

  2012cites this paper
• [Severe hemorrhage in a patient with metastatic colorectal cancer - case 8/2012].

  2012cites this paper
• Plasma D-dimer in Patients with Solid Malignant Tumors

  2009cites this paper
• Disseminated Intravascular Coagulation (DIC) in cancer.

  2009cites this paper
• Cancer de prostate et coagulation intravasculaire disséminée : une revue de la littérature

  2008cites this paper
• Niño con leucemia no linfoblástica aguda e hiperleucocitosis

  2007cites this paper
• Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.

  2006cites this paper
• Cardiac metastases

  2006cites this paper
• Hemostatic changes in patients with brain tumors

  2005cites this paper
• Sndrome de Trousseau y dficit de antitrombina III

  2005cites this paper
• [Trousseau's syndrome and antithrombin-III deficiency].

  2005cites this paper
• Advanced Endodermal Sinus Tumor With Contralateral Dermoid Tumor During Pregnancy: A Case Report and Literature Review

  2004cites this paper
• Prognostic significance of hemostatic parameters in patients with lung cancer.

  2004cites this paper
• HEMOSTATIC SIDE EFFECTS OF HIGH-DOSE METHOTREXATE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

  2004cites this paper
• [Prostate cancer and acute disseminated intravascular coagulation. Therapeutic management based on three cases].

  2003cites this paper
• Fatal Thrombocytopenia and Thrombocytopathia: An Unusual Onset of Non-Small Cell Lung Cancer

  2003cites this paper
• Peripheral Venous Pathomorphology and Pathophysiology

  2002cites this paper
• Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor?

  2002cites this paper
• Paraneoplastic dermatoses.

  2002cites this paper
• Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia.

  2001cites this paper
• Bleeding and thrombotic complications in critically ill patients with cancer.

  2001cites this paper
• The Hemostatic Changes in Active Pulmonary Tuberculosis.

  2001cites this paper
• Simultaneous bilateral central retinal vein occlusion associated with anticardiolipin antibodies in leukemia.

  2001cites this paper
• Perioperative development of a thrombogenic risk profile in patients with carcinomas of the breast: a cause of increased thrombosis.

  2000cites this paper
• Thrombocytes Are the Major Source for Soluble Vascular Endothelial Growth Factor in Peripheral Blood

  2000cites this paper
• Occlusive Vascular Disease in Cancer

  2000cites this paper
• Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.

  2000cites this paper
• Neoplastic thrombotic endocarditis of the tricuspid valve in a patient with carcinoma of the thyroid. Report of a case.

  1999cites this paper
• Utility of abdominal sonography in patients with idiopathic deep vein thrombosis

  1999cites this paper
• Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients.

  1999cites this paper
• Risk Factors for Venous Thrombotic Disease

  1999cites this paper
• PERIOPERATIVE ANTICOAGULATION AND THROMBOLYSIS IN CONGENITAL AND ACQUIRED COAGULOPATHIES

  1999cites this paper
• [Skin necrosis in the front foot area during anticoagulation with phenprocoumon].

  1999cites this paper
• Tumor microcirculation and its significance in therapy: possible role of omega-3 fatty acids as rheological modifiers.

  1998cites this paper
• Transient Increase in Thrombin Generation during Radiotherapy of Uterine Carcinoma: A Preliminary Study using Thrombin-Antithrombin III Complex Measurements

  1998cites this paper
• Gerinnungsstörungen bei soliden Tumoren

  1997cites this paper
• Incidence of objectively diagnosed thromboembolic disease in cancer patients undergoing cytotoxic chemotherapy and / or hormonal therapy

  1997cites this paper
• Cancer-related thromboembolic disease in patients with solid tumours: a retrospective analysis.

  1997cites this paper
• Bleeding, clotting and cancer.

  1997cites this paper
• Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.

  1997cites this paper
• Vascular Endothelium

  1996cites this paper
• Diagnosis of cancer‐associated vascular disorders

  1996cites this paper
• Expression of tissue-type plasminogen activator, plasminogen activator inhibitor and von Willebrand factor in the supernatant of endothelial cell cultures in response to the seeding of adenocarcinoma cell line HRT-18.

  1996cites this paper
• Endothelial Function and Malignant Coagulopathy

  1996cites this paper
• Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study.

  1996cites this paper
• [Disseminated intravascular coagulation associated with prostatic cancer].

  1995cites this paper
• Medical Characteristics of 61 Unwarranted Malpractice Claims

  1995cites this paper
• Acute disseminated intravascular coagulation syndrome in cancer patients.

  1995cites this paper
• State-of-the-Art Review: Usefulness of Laboratory Techniques for Evaluating Antithrombotic Efficacy of New Therapeutic Strategies

  1995cites this paper
• Deep venous thrombosis and pulmonary artery embolism in high‐grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance

  1995cites this paper
• Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients.

  1995cites this paper
• Platelet activation and platelet lipid composition in pulmonary cancer.

  1995cites this paper
• Coagulation intravasculaire disséminée associée au cancer de la prostate

  1995cites this paper
• Plasma levels of soluble fibrin in patients with malignancy-associated disseminated intravascular coagulation

  1994cites this paper
• Should Cerebral Ischemic Events in Cancer Patients Be Considered a Manifestation of Hypercoagulability?

  1994cites this paper
• [Detection of ovarian adenocarcinoma in the occasion of cerebrovascular complication associated with consumption coagulopathy].

  1994cites this paper
• [Thrombophilia in tumor diseases. Point of origin, relationship to the course of illness, effect of therapy].

  1994cites this paper
• Omega-3 fatty acids can improve radioresponse modifying tumor interstitial pressure, blood rheology and membrane peroxidability.

  1994cites this paper
• Myeloproliferative and metabolic causes.

  1994cites this paper
• Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer.

  1994cites this paper
• Application of cancer procoagulant as an early detection tumor marker

  1994cites this paper
• 10 Myeloproliferative and metabolic causes

  1994cites this paper
• Importance of image-guided stereotactic biopsy to confirm diagnosis in an oncological setting

  1994cites this paper
• Découverte d'un adénocarcinome ovarien à l'occasion d'un accident vasculaire cérébral associé à une coagulopathie de consommation

  1994cites this paper
• Assessment of hypercoagulability in patients with cancer using the Sonoclot Analyzer and thromboelastography.

  1994cites this paper
• Cellular mechanisms for the activation of blood coagulation.

  1994cites this paper
• Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.

  1994cites this paper
• Clinical implications of laboratory testing for the thrombophilic disorders.

  1993cites this paper
• Markers of procoagulant imbalance in patients with localized melanomas and autoimmune disorders

  1993cites this paper
• Acute ischaemia of the lower limb: an unusual presenting feature of acute lymphoblastic leukaemia.

  1993cites this paper
• Disseminated Intravascular Coagulation

  1993cites this paper
• Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo

  1993cites this paper
• Fibrinolytic mechanisms in tumor growth and spreading

  1992cites this paper
• Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'.

  1992cites this paper
• Cerebral Infarction Associated With Protein C Deficiency

  1992cites this paper
• Acute Myeloid Leukaemia

  1992cites this paper
• Specific expression of the annexin VIII gene in acute promyelocytic leukemia.

  1992cites this paper
• Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma.

  1992cites this paper
• Modulation of tissue factor on human monocytes by cisplatin and adriamycin

  1992cites this paper
• Cancer Cell Procoagulants and Their Role in Malignant Disease

  1992cites this paper
• Cancer cell procoagulants and their implications.

  1992cites this paper
• Spontaneous peripheral arterial microembolization

  1992cites this paper
• The inhibition of platelet aggregation of metastatic H-ras-transformed 10T1/2 fibroblasts with castanospermine, an N-linked glycoprotein processing inhibitor.

  1991cites this paper
• Hemostasis in malignancy.

  1991cites this paper
• Bleeding in acute promyelocytic leukemia (APL): fibrinolysis or defibrination?

  1991cites this paper